Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Education empowers Canadians, but raises risks of overwork, work-family stress

  • Imagination, reality flow in opposite directions in the brain

  • Why we need to fund newer blood-thinning agents to prevent strokes

  • Social sensing game detects classroom bullies

  • From architect to social worker: Complex jobs may protect memory and thinking later in life

  • Digging for answers: Gender inequality in archeology?

  • New approach for treating ALS: Re-evaluation of older drugs?

  • Job authority increases depression symptoms in women, decreases them in men

  • Only half of patients take their medications as prescribed: Are there interventions that will help them?

  • What's behind our music tastes? Some common perceptions

  •